General Information
Revision date
2020-09-01
Product name
Mycophenolic Acid* Delayed-Release Tablets, USP
1.2.1 Relevant identified uses
as mycophenolate sodium)
Manufacturer Name
Concord Biotech Limited
Icons in SDS
Company Information
company name
Concord Biotech Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Mycophenolic acid delayed-release tablets are contraindicated in patients with a hypersensitivity to mycophenolate sodium, mycophenolic acid, mycophenolate mofetil, or to any of its excipients. Reactions like rash, pruritus, hypotension, and chest pain have been observed in clinical trials and post marketing reports.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
